Aileen Faist Selected Research

2- (2- chloro- 4- iodophenylamino)- N- 3,4- difluorobenzoic acid

1/2022

The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aileen Faist Research Topics

Disease

2	Infections 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
1	Fibrosarcoma 01/2022
1	Human Influenza (Influenza) 01/2022

Drug/Important Bio-Agent (IBA)

1	CytokinesIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	2- (2- chloro- 4- iodophenylamino)- N- 3,4- difluorobenzoic acidIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	NucleosidesIBA 01/2021
1	VaccinesIBA 01/2021
1	remdesivirIBA 01/2021

Therapy/Procedure

1	Therapeutics 01/2021